The anticoagulant edoxaban may be just as effective as warfarin for preventing heart attack or stroke in patients with atrial fibrillation (AF) who undergo transcatheter aortic valve replacement (TAVR ...
A large-scale international study led by Mount Sinai has yielded the first risk score that can help predict mortality for patients with atrial fibrillation (AFib) who have undergone a successful ...
BACKGROUND: Clinical evidence on the safety and effectiveness of using direct oral anticoagulants (DOACs) in patients with atrial fibrillation after transcatheter aortic valve replacement (TAVR) ...
A new study compares edoxaban anticoagulant with the standard of care in large randomized clinical trial. The anticoagulant edoxaban may be just as effective as warfarin for preventing heart attack or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results